Facteurs influençant la prescription de la médication cardioprotectrice recommandée chez les patients avec une maladie artérielle périphérique
|Advisor:||Bairati, Isabelle; Douville, Yvan|
|Abstract:||Introduction: Guidelines recommend that patients with peripheral arterial disease (PAD) should be medically treated to reduce the occurrence of serious cardiovascular events. Objective: To identified factors associated with the prescription of preventive therapies in patients with PAD. Methods: Consecutive patients with PAD (n=362) who underwent peripheral percutaneous transluminal angioplasty between 2008 and 2010 in one tertiary care center (CHU de Quebec, Canada) were considered for the study. Data were collected from the medical charts. The main outcome was the combined prescription of three therapies. Results: A total of 52% of the patients received the three combined therapies. Having at least three cardiovascular risk factors (Odds Ratio (OR)=4.51; 95% CI: 2.76-7.37) was the factor most strongly associated with the prescription of the combined therapies. Conclusion: Canadian patients with PAD are still not optimally managed. We still need to better understand the barriers and facilitators to the application of the guidelines in PAD patients.|
|Document Type:||Mémoire de maîtrise|
|Open Access Date:||24 April 2018|
|Collection:||Thèses et mémoires|
All documents in CorpusUL are protected by Copyright Act of Canada.